Psychiatry’s next top model: cause for a re-think on drug models of psychosis and other psychiatric disorders RL Carhart-Harris, S Brugger, DJ Nutt and JM Stone Despite the widespread application of drug modelling in psychiatric research, the relative value of
A web-based survey on mephedrone Mephedrone (4-methylmethcathinone) is a substituted cathinone with stimulant properties. The popularity of mephedrone in the UK rose sharply in 2009 after it became seen as a legal, cheap and easily available alternative to MDMA (ecstasy).
Experienced Drug Users Assess the Relative Harms and Benefits of Drugs: A Web-Based Survey A web-based survey was used to consult the opinions of experienced drug users on matters related to drug harms. We identified a rare sample of
Professor David Nutt discusses his book Drugs – Without the Hot Air, and argues that society’s prohibition of psychedelic substances is preventing groundbreaking science
David Nutt, former government chief drugs adviser, says banning of legal highs has already been destructive to Parkinson’s and anti-smoking research
For 40 years, Amanda Feilding, Countess of Wemyss and March, has believed psychedelics are an effective treatment for depression and anxiety. Now a growing number of scientists agree
To date, the project has been partially funded by Imperial College London and the Beckley Foundation. However, researchers are now in need of £25,000 to analyze scans. Scientists belief LSD (lysergic acid diethylamide) can be used to treat addictions, depression
Researchers warn that patients are missing out on potential benefits due to prohibitive regulations on research into recreational drugs